Skip to main content
Clinical Trials/DRKS00021415
DRKS00021415
Recruiting
Not Applicable

Prediction of hematotoxicity and non-hematological toxicity of systemic therapies and other clinical outcome parameters for patients with locally advanced gastric cancer or gastroesophageal transition (AEG I-III by Siewert) and patients with pancreatic carcinoma

niversitäres Krebszentrum Leipzig (UCCL)0 sites35 target enrollmentApril 30, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C15
Sponsor
niversitäres Krebszentrum Leipzig (UCCL)
Enrollment
35
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 30, 2020
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitäres Krebszentrum Leipzig (UCCL)

Eligibility Criteria

Inclusion Criteria

  • Patients with locally advanced carcinoma of the stomach, gastroesophageal transition (AEG I\-III by Siewert) or pancreas receiving systemic chemotherapy, signed consent form, legal age (\= 18 years)

Exclusion Criteria

  • Minority (\< 18 years), missing consent form, presence of pronounced anemia (the hemoglobin value of \<\=4\.6 mmol/l serves as a guideline), pregnant and nursing patients

Outcomes

Primary Outcomes

Not specified

Similar Trials